Hydroxyzine and QT Prolongation: What You Need to Know About the Cardiac Risk

Hydroxyzine has been used for decades to treat anxiety, itching, and nausea. It’s cheap, effective, and widely prescribed - especially in older adults and people with chronic skin conditions. But in recent years, doctors have learned something alarming: this common antihistamine can trigger a dangerous heart rhythm problem called QT prolongation, which may lead to a life-threatening arrhythmia known as Torsade de Pointes.

What Is QT Prolongation and Why Does It Matter?

Your heart beats because of electrical signals that move through muscle cells in a precise sequence. The QT interval on an ECG measures how long it takes for the heart’s lower chambers to recharge after each beat. If that interval gets too long, the heart can misfire, leading to irregular, rapid beats. In the worst cases, this turns into Torsade de Pointes - a twisting pattern on the ECG that can collapse into ventricular fibrillation and sudden death.

Hydroxyzine interferes with a key ion channel in the heart called hERG. This channel lets potassium escape from heart cells during repolarization. When hydroxyzine blocks it, the heart takes longer to reset. That’s what stretches out the QT interval. It doesn’t happen in everyone. But in people with certain risk factors, even a normal dose can be enough to trigger trouble.

Who Is at Risk?

Hydroxyzine isn’t dangerous for every person. But certain factors stack the odds:

• Age 65 or older - metabolism slows, and the drug builds up
• Low potassium or magnesium levels - common in people on diuretics, with kidney disease, or eating poorly
• Already taking other QT-prolonging drugs - like certain antibiotics, antidepressants, or antiarrhythmics
• History of heart disease, bradycardia, or prior long QT syndrome
• Genetic factors - some people are poor metabolizers of hydroxyzine due to CYP2D6 enzyme variants

One 2022 case report described a 68-year-old woman with no prior heart problems who developed Torsade de Pointes after taking 50 mg of hydroxyzine for anxiety. She was also on amiodarone - a known QT-prolonging drug. That combination was deadly. Another case involved a 45-year-old man with undiagnosed long QT syndrome who passed out 15 minutes after taking 25 mg for hives. He survived, but barely.

How Much Is Too Much?

Before 2015, hydroxyzine was often prescribed at doses up to 150 mg per day. Now, regulators have changed that.

The European Medicines Agency (EMA) reviewed all available data in 2015 and found a clear link between hydroxyzine and QT prolongation. Their conclusion? The risk is real, but manageable - if you follow strict rules:

• Maximum daily dose for adults: 100 mg
• Maximum daily dose for adults over 65: 50 mg
• For children: 2 mg per kg of body weight (up to 40 kg)

Even these doses can be risky if other factors are present. A 2021 survey of hospital pharmacists found that 63% had seen hydroxyzine prescribed to patients with two or more risk factors - despite clear guidelines against it.

How Hydroxyzine Compares to Other Antihistamines

Not all antihistamines are created equal when it comes to heart risk.

Second-generation antihistamines like cetirizine and loratadine barely affect the QT interval. They’re preferred for long-term use because they don’t cross into the brain as much - which means less drowsiness and less cardiac danger.

Among first-generation antihistamines, hydroxyzine is on the higher end of risk. It’s similar to diphenhydramine (Benadryl), but slightly more potent at blocking hERG channels. That’s because of its unique chemical structure. Studies show hydroxyzine binds tightly to the inner part of the hERG channel, blocking potassium flow more effectively than most other antihistamines.

Compare that to drugs like dofetilide - used specifically to treat arrhythmias - which carry a 1-8% risk of Torsade de Pointes. Hydroxyzine’s risk is much lower, but it’s still significant enough that you can’t ignore it.

What Doctors Should Do Before Prescribing

Prescribing hydroxyzine safely now requires more than just checking a box. Here’s what works:

1. Check the patient’s QTc interval on a 12-lead ECG. Normal is under 450 ms for men, under 470 ms for women. If it’s over 500 ms, don’t prescribe it.
2. Review all medications using the CredibleMeds database. If the patient is on another drug marked as “Known Risk of TdP,” avoid hydroxyzine.
3. Check electrolytes. Potassium below 4.0 mmol/L and magnesium below 1.8 mg/dL raise risk.
4. Ask about heart history. Did they ever faint for no reason? Have they had unexplained palpitations?
5. Document everything. Many hospitals now require a note like: “QTc checked, no contraindications, risk discussed.”

Electronic health records in the U.S. now often block hydroxyzine orders if the patient has a QTc over 500 ms or is on another high-risk drug. This isn’t overkill - it’s necessary.

What’s Changing in Prescribing Practices?

Since the 2015 EMA review, things have shifted.

In the U.S., outpatient prescriptions for hydroxyzine dropped from 18.3 million in 2014 to 12.7 million in 2022. That’s a 30% decline. Elderly prescriptions fell even more - by 37% within a year of the new guidelines.

The American Geriatrics Society now lists hydroxyzine as a “Potentially Inappropriate Medication” for older adults. Meanwhile, the American Academy of Dermatology still recommends it for chronic itching - but only if the patient has been screened for cardiac risk.

Doctors are turning to alternatives:

• Gabapentin for pruritus - prescriptions rose 62% between 2015 and 2022
• Mirtazapine for insomnia and anxiety in older patients - use increased 45%
• Non-sedating antihistamines like cetirizine - now first-line for itching

What About the Future?

Research is moving fast. A 2023 study found that people with CYP2D6 poor metabolizer status had over three times the risk of QT prolongation from hydroxyzine. That means genetic testing could one day help identify who’s safest to prescribe it to.

There’s also a new drug in early trials - VH-01 - designed to keep hydroxyzine’s antihistamine effects but remove its hERG-blocking action. Early results show 87% less hERG inhibition at the same dose. If it works, it could replace hydroxyzine entirely.

The 2025 European Society of Cardiology guidelines are expected to ban chronic hydroxyzine use completely. Only single doses for procedural anxiety - like before a dental visit - may be allowed.

What Should You Do?

If you’re taking hydroxyzine:

• Don’t stop suddenly - talk to your doctor first.
• Ask if you’ve had an ECG recently.
• Review your other medications. Are you on anything that can prolong QT?
• If you feel dizzy, lightheaded, or have heart palpitations after taking it - call your doctor.

If you’re a patient over 65, or have kidney disease, heart disease, or take multiple medications - ask if there’s a safer option. Hydroxyzine isn’t inherently evil. But it’s not the harmless sedative it was once thought to be.

The era of assuming antihistamines are universally safe is over. Hydroxyzine needs the same caution as heart medications - not because it’s dangerous for everyone, but because it can be deadly for some.